Topic

New Jersey

A collection of 536 issues

Renewing Upstaza (Eladocagene Exuparvovec) Approval with Blue Cross Blue Shield in New Jersey: 2025 Timeline and Requirements

Answer Box: Upstaza (eladocagene exuparvovec) renewal with Blue Cross Blue Shield in New Jersey requires annual reauthorization with updated clinical documentation. Start 60-90 days before expiration. Submit: genetic confirmation, specialist letter documenting response/safety, failed conventional therapy records, and center attestation. Use your plan's specialty pharmacy portal or

How to Get Cerezyme (Imiglucerase) Approved by UnitedHealthcare in New Jersey: Complete Appeals Guide

Answer Box: Getting Cerezyme Covered by UnitedHealthcare in New Jersey Cerezyme (imiglucerase) requires prior authorization from UnitedHealthcare/OptumRx in New Jersey and may face step therapy requirements. To get coverage: 1. Submit PA request via UnitedHealthcare Provider Portal with Gaucher disease confirmation and specialist documentation 2. Request step therapy exception

How to Get Qinlock (ripretinib) Covered by Humana in New Jersey: Prior Authorization Forms, Appeals Timeline, and Medical Necessity Requirements

Answer Box: Quick Path to Qinlock Coverage Getting Qinlock (ripretinib) covered by Humana in New Jersey requires prior authorization with documentation of failed kinase inhibitor therapy. Your oncologist must submit a PA request showing you've tried and failed imatinib, sunitinib, and regorafenib for advanced GIST. If denied, you

How to Get Opzelura (ruxolitinib cream) Covered by Blue Cross Blue Shield in New Jersey: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Opzelura Covered in New Jersey Opzelura (ruxolitinib cream) requires prior authorization from Blue Cross Blue Shield in New Jersey. Your fastest path to approval: Have your dermatologist document failed trials of topical corticosteroids and calcineurin inhibitors, then submit the PA request through Horizon BCBSNJ's provider

How to Get Revlimid (lenalidomide) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Get Revlimid (lenalidomide) Covered by Aetna CVS Health in New Jersey Yes, Aetna CVS Health covers Revlimid (lenalidomide) in New Jersey with prior authorization. Your fastest path to approval: 1) Confirm your prescriber and pharmacy are REMS-certified, 2) Submit complete prior authorization via Availity portal with diagnosis, clinical

Getting Vyondys 53 (Golodirsen) Approved by Blue Cross Blue Shield in New Jersey: Complete Coverage Guide and Appeal Process

Answer Box: Quick Path to Vyondys 53 Coverage Getting Vyondys 53 (golodirsen) covered by Blue Cross Blue Shield in New Jersey requires prior authorization with genetic testing confirming an exon 53 skip-amenable DMD mutation. First step: Have your neurologist complete the BCBS prior authorization form with genetic test results and

Get Xospata (Gilteritinib) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and Medical Necessity Guide

Answer Box: Fastest Path to Approval To get Xospata (gilteritinib) covered by Cigna in New Jersey: Your hematologist/oncologist must submit prior authorization with FLT3-mutation test results (FDA-approved), AML diagnosis confirmation, and documentation of relapsed/refractory status. If denied, file internal appeals within 180 days, then external review through New

How to Get Rapivab (Peramivir) Covered by UnitedHealthcare in New Jersey: Prior Authorization Guide 2025

Quick Answer: Getting Rapivab Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Rapivab (peramivir) through OptumRx and is not on the 2024 commercial formulary, making it non-formulary with higher costs or potential denial. To get coverage: (1) Your doctor submits a prior authorization via the UnitedHealthcare Provider

How to Get Aldurazyme (Laronidase) Covered by Cigna in New Jersey: Complete Coding & Appeals Guide

Answer Box: Getting Aldurazyme (Laronidase) Covered by Cigna in New Jersey Aldurazyme (laronidase) requires prior authorization from Cigna and is typically covered under the medical benefit. Your fastest path: 1) Have your specialist submit a PA request through CoverMyMeds or call 1-800-882-4462 with complete MPS I documentation, 2) Use correct

Denied for Dojolvi (Triheptanoin) by UnitedHealthcare in New Jersey? Complete Appeal Guide with Templates

Answer Box: UnitedHealthcare requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of long-chain fatty acid oxidation disorder (LC-FAOD) and specialist prescription. No step therapy applies. If denied, request peer-to-peer review immediately, then file internal appeal within 180 days. After exhausting internal appeals, use New Jersey's IHCAP external